Activation of guinea-pig platelets induced by convulxin, a substance extracted from the venom of Crotalus durissus cascavella

Abstract

Convulxin (Cx), a component of the venom of the snake Crotalus durissus cascavella, induced the concentration-dependent of ATP and by the formation of thromboxanes (Tx). Platelet activation by Cx was not due to potential contaminants found in the crude snake venom, such as phospholipase A 2 and clotting enzymes. Aspirin (50–100 μM) failed to interfere with the platelet effects of Cx, demonstrating independence from cyclo-oxygenase. In contrast, indomethacin (50 μM) displayed a distinct inhibitory activity on the effects of Cx, as compared to aspirin, and thus exerts cyclo-oxygenase-independent effects on platelet activation. The ADP scavenger creatine phosphate/creatine phosphokinase (CP/CPK) inhibited aggregation by Cx used at concentrations below 6–8 times the threshold, but failed to interfere with higher amounts. Platelet aggregation by Cx was inhibited and reversed once established by EDTA (5 mM) and by prostacyclin (0.1–1 μM). Cx-induced activation of platelets is thus Ca 2+-dependent and liable to control by the adenylate cyclase-cyclic AMP system. Convulxin induced hypotension, bronchoconstriction and thrombocytopenia when injected i.v. to the anesthetised guinea pig at 0.3–3 μg/kg. Aspirin and indomethacin (20 and 5 mg/kg respectively) mepyramine and methysergide (0.2 mg/kg) failed to interfere with these effects, but the composition of either aspirin or indomethacin with methylsergide and meypryamine, suppressed the bronchial effects of Cx, leaving the hypotensive and thrombopenic effects unchanged. This synergism remains unexplained. Bronchoconstriction was platelet-dependent, being suppressed by platelet depletion with antiplatelet serum or by i.v. prostacyclin (1–10 μg/kg).